- Home
- INDV vs MMI Comparison
INDV vs MMI Comparison
Compare INDV & MMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDV
- MMI
- Stock Information
- Founded
- INDV 1994
- MMI 1971
- Country
- INDV United States
- MMI United States
- Employees
- INDV N/A
- MMI N/A
- Industry
- INDV Biotechnology: Pharmaceutical Preparations
- MMI Real Estate
- Sector
- INDV Health Care
- MMI Finance
- Exchange
- INDV Nasdaq
- MMI Nasdaq
- Market Cap
- INDV 1.2B
- MMI 1.3B
- IPO Year
- INDV N/A
- MMI 2013
- Fundamental
- Price
- INDV $9.01
- MMI $31.25
- Analyst Decision
- INDV Strong Buy
- MMI Sell
- Analyst Count
- INDV 2
- MMI 1
- Target Price
- INDV $14.50
- MMI $30.00
- AVG Volume (30 Days)
- INDV 944.7K
- MMI 143.3K
- Earning Date
- INDV 04-24-2025
- MMI 05-07-2025
- Dividend Yield
- INDV N/A
- MMI 1.60%
- EPS Growth
- INDV N/A
- MMI N/A
- EPS
- INDV N/A
- MMI N/A
- Revenue
- INDV $1,188,000,000.00
- MMI $696,060,000.00
- Revenue This Year
- INDV N/A
- MMI $11.69
- Revenue Next Year
- INDV $4.26
- MMI $24.07
- P/E Ratio
- INDV N/A
- MMI N/A
- Revenue Growth
- INDV 8.69
- MMI 7.76
- 52 Week Low
- INDV $7.33
- MMI $29.36
- 52 Week High
- INDV $19.78
- MMI $42.80
- Technical
- Relative Strength Index (RSI)
- INDV 43.38
- MMI 38.55
- Support Level
- INDV $8.97
- MMI $30.62
- Resistance Level
- INDV $9.54
- MMI $32.00
- Average True Range (ATR)
- INDV 0.50
- MMI 1.35
- MACD
- INDV -0.02
- MMI -0.02
- Stochastic Oscillator
- INDV 33.33
- MMI 32.25
About INDV Indivior PLC
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
About MMI Marcus & Millichap Inc.
Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.